No abstract available
Publication types
-
Comment
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Clinical Trials as Topic
-
Drug Delivery Systems
-
Humans
-
Receptors, Vascular Endothelial Growth Factor
-
Recombinant Fusion Proteins / adverse effects
-
Recombinant Fusion Proteins / therapeutic use*
-
Vascular Endothelial Growth Factor A
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Recombinant Fusion Proteins
-
Vascular Endothelial Growth Factor A
-
aflibercept
-
Bevacizumab
-
Receptors, Vascular Endothelial Growth Factor